These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 8640718

  • 21. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G, del Giudice L, Palatron S, Giarin E, Cazzaniga G, Biondi A, Basso G.
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [Abstract] [Full Text] [Related]

  • 22. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
    Neale GA, Menarguez J, Kitchingman GR, Fitzgerald TJ, Koehler M, Mirro J, Goorha RM.
    Blood; 1991 Aug 01; 78(3):739-47. PubMed ID: 1859886
    [Abstract] [Full Text] [Related]

  • 23. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
    Sudhakar N, Nancy NK, Rajalekshmy KR, Ramanan G, Rajkumar T.
    Am J Hematol; 2007 Mar 01; 82(3):215-21. PubMed ID: 17133429
    [Abstract] [Full Text] [Related]

  • 24. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
    Brüggemann M, van der Velden VH, Raff T, Droese J, Ritgen M, Pott C, Wijkhuijs AJ, Gökbuget N, Hoelzer D, van Wering ER, van Dongen JJ, Kneba M.
    Leukemia; 2004 Apr 01; 18(4):709-19. PubMed ID: 14961040
    [Abstract] [Full Text] [Related]

  • 25. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P, Mortuza FY, Hoffbrand AV, Foroni L.
    Haematologica; 2002 Nov 01; 87(11):1126-34. PubMed ID: 12414341
    [Abstract] [Full Text] [Related]

  • 26. Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye.
    Li AH, Forestier E, Rosenquist R, Roos G.
    Exp Hematol; 2002 Oct 01; 30(10):1170-7. PubMed ID: 12384148
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW, Liang R, Kwong YL, Chan V.
    Am J Hematol; 1996 Jul 01; 52(3):171-7. PubMed ID: 8756082
    [Abstract] [Full Text] [Related]

  • 30. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
    Toubai T, Tanaka J, Ota S, Fukuhara T, Hashino S, Kondo T, Kasai M, Kakinoki Y, Masauzi N, Morioka M, Kawamura T, Iwasaki H, Asaka M, Imamura M.
    Am J Hematol; 2005 Nov 01; 80(3):181-7. PubMed ID: 16247752
    [Abstract] [Full Text] [Related]

  • 31. V-J junctional sequences of T cell receptor gamma gene in acute lymphocytic leukemia.
    Dong S, Huang W, Tong J, Wang Z, Chen S, Chen Z, Gu L, Li X, Xie J.
    Sci China B; 1995 Feb 01; 38(2):202-10. PubMed ID: 7755873
    [Abstract] [Full Text] [Related]

  • 32. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
    Dawidowska M, Derwich K, Szczepański T, Jółkowska J, Witt M, Wachowiak J.
    Med Wieku Rozwoj; 2006 Feb 01; 10(1 Pt 2):323-34. PubMed ID: 17028396
    [Abstract] [Full Text] [Related]

  • 33. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).
    Shahkarami S, Mehrasa R, Younesian S, Yaghmaie M, Chahardouli B, Vaezi M, Rezaei N, Nikbakht M, Alimoghaddam K, Ghavamzadeh A, Tavakkoly-Bazzaz J, Ghaffari SH.
    Ann Hematol; 2018 Apr 01; 97(4):585-595. PubMed ID: 29392424
    [Abstract] [Full Text] [Related]

  • 34. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O, Peruta B, Tosi M, Guerini V, Salvi A, Zanotti MC, Oldani E, Grassi A, Intermesoli T, Micò C, Rossi G, Fabris P, Lambertenghi-Deliliers G, Angelucci E, Barbui T, Bassan R, Rambaldi A.
    Haematologica; 2007 May 01; 92(5):612-8. PubMed ID: 17488684
    [Abstract] [Full Text] [Related]

  • 35. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L, Zhang LP, Li ZG, Cheng YF, Tian KG, Lu AD.
    Zhonghua Er Ke Za Zhi; 2005 Mar 01; 43(3):170-3. PubMed ID: 15833185
    [Abstract] [Full Text] [Related]

  • 36. Molecular detection of minimal residual disease is associated with early relapse in adult acute lymphoblastic leukemia.
    Specchia G, Liso A, Pannunzio A, Albano F, Mestice A, Pastore D, Liso V.
    Haematologica; 2004 Oct 01; 89(10):1271-3. PubMed ID: 15477219
    [Abstract] [Full Text] [Related]

  • 37. Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan.
    Imashuku S, Terui K, Matsuyama T, Asami K, Tsuchiya S, Ishii E, Kawa K, Kosaka Y, Eguchi H, Tsuchida M, Ikuta K, Kato S, Koizumi S, Okamura J, Morimoto A, Hibi S, Hamaoka K, multi-institutional collaborative study in Japan.
    Bone Marrow Transplant; 2003 Jun 01; 31(12):1127-35. PubMed ID: 12796792
    [Abstract] [Full Text] [Related]

  • 38. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
    Seriu T, Hansen-Hagge TE, Erz DH, Bartram CR.
    Leukemia; 1995 Feb 01; 9(2):316-20. PubMed ID: 7869770
    [Abstract] [Full Text] [Related]

  • 39. Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.
    Gameiro P, Moreira I, Yetgin S, Papaioannou M, Potter MN, Prentice HG, Hoffbrand AV, Foroni L.
    Br J Haematol; 2002 Dec 01; 119(3):685-96. PubMed ID: 12437645
    [Abstract] [Full Text] [Related]

  • 40. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ, Condon J, Hughes E, Neoh SH, Nicholson I, Sykes PJ, Tauro G, Ekert H, Waters K, Toogood I.
    Leukemia; 1993 Oct 01; 7(10):1514-20. PubMed ID: 8412313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.